Bionano Genomics, Inc. (BNGO) vs Dyadic International, Inc. (DYAI)

A side-by-side comparison of Bionano Genomics, Inc. and Dyadic International, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BNGO vs DYAI

growth of $100 · dividends reinvested · last 8y
BNGO -100.0% (-62.5%/yr)DYAI -68.9% (-13.6%/yr)DYAI compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $1002020202220242026$0$31
BNGO DYAI

BNGO vs DYAI: by the numbers

  • •DYAI is the larger company ($17M vs $16M market cap).
  • •Both run net losses; BNGO's is the smaller (-106.58% vs -219.50% net margin).
  • •BNGO grew revenue faster over the past five years (17.97% vs -5.11% CAGR).

Metrics side by side

Valuation

MetricBNGODYAI
P/S ratio0.544.96
P/B ratio0.52N/A

Profitability

MetricBNGODYAI
Gross margin21.95%-88.25%
Operating margin-116.95%-579.88%
Net margin-106.58%-219.50%
ROE-101.76%N/A
ROIC-85.72%-279.48%

Growth (annualized)

MetricBNGODYAI
Revenue CAGR (5Y)17.97%-5.11%
Total return CAGR (5Y)-78.37%-38.53%

Frequently asked

Which has grown faster, BNGO or DYAI?
Over the past five years, BNGO grew revenue faster — BNGO at a 17.97% CAGR versus DYAI at -5.11%.
How have BNGO and DYAI total returns compared?
Over the past 5 years, BNGO delivered -78.37% and DYAI delivered -38.53% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.